Las Vegas, NV -- (SBWIRE) -- 12/06/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Goodrich Petroleum Corporation (NYSE:GDP), Crocs, Inc. (NASDAQ:CROX), VIVUS, Inc. (NASDAQ:VVUS)
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) managed to keep its fall at -2.73% on below -normal volume of 1.45M shares. The stock settled at $4.98 after floating in a range of $4.96 to $5.14. Its latest price has reached market capitalization of $413.85 million. Its 52-week range has been $3.70 to $11.88. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. As of December 31, 2011, it had two drug candidates in clinical trials for treating multiple types of cancer and several drug candidates in the preclinical-stage of development.
Has SNTA Found The Bottom and Ready To Move Up? Find Out Here
Goodrich Petroleum Corporation (NYSE:GDP) traded down on a volume of 1.43 million, lower than its standard daily volume. Shares have dropped-1.26% to $19.59. Over the last twelve months, the stock has gained 117.43% and faced a worst price of $7.95. Goodrich Petroleum Corporation is an independent oil and natural gas company engaged in exploration, development and production of oil and natural gas on properties primarily in Northwest Louisiana, East Texas and South Texas. It includes the Haynesville Shale and Cotton Valley Taylor Sand in Northwest Louisiana and East Texas, the Eagle.
Has GDP Found The Bottom And Ready To Gain Momentum? Find Out Here
Crocs, Inc. (NASDAQ:CROX) settled -1.63% lower at $13.26 on below -normal volume of 1.43M shares during the last trading day. The stock has its 12-month high at $17.95and 52-week low price was $11.96. It traded in a range of $13.23 to $13.49 during the last trading day. Crocs, Inc is a designer, manufacturer and distributor of footwear and accessories for men, women and children. As of December 31, 2012, the Company sold its products in more than 90 countries through domestic and international retailers and distributors and directly to end-user consumers through its Company-operated retail stores, outlets, kiosks and Webstores. Its footwear products are divided into four product offerings: Core-Comfort, Active, Casual and Style.
Will CROX Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, VIVUS, Inc. (NASDAQ:VVUS) was down on low volume, trading at a volume of 1.42M shares versus its average daily volume of 1.90 million shares. At $9.63, the stock has attained market capitalization of $979.42 million. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese).
Why Should Investors Buy VVUS After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)